Skip to main content
. 2022 Sep 14;17:2277–2288. doi: 10.2147/COPD.S367819

Table 3.

Overall and Subgroup Trends for Drugs Used in Nebulization Therapy

Drugs Overall (in %) SEC A (in %) SEC B (in %) Male (in %) Female (in %)
Formoterol + Budesonide 46 52 39 45 46
Budesonide 31 33 24 26 34
Levosalbutamol + Ipratropium 29 33 24 34 26
Levosalbutamol 20 20 18 19 22
Salbutamol 19 19 18 19 18
Levosalbutamol + Budesonide 3 2 4 4 2
Glycopyrrolate 3 6 0 6 0
Salmeterol + Fluticasone Propionate 2 2 2 4 0